Search by Drug Name or NDC
NDC 68382-0184-01 Glipizide and Metformin Hydrochloride 2.5; 250 mg/1; mg/1 Details
Glipizide and Metformin Hydrochloride 2.5; 250 mg/1; mg/1
Glipizide and Metformin Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is GLIPIZIDE; METFORMIN HYDROCHLORIDE.
MedlinePlus Drug Summary
Glipizide is used along with diet and exercise, and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Glipizide is in a class of medications called sulfonylureas. Glipizide lowers blood sugar by causing the pancreas to produce insulin (a natural substance that is needed to break down sugar in the body) and helping the body use insulin efficiently. This medication will only help lower blood sugar in people whose bodies produce insulin naturally. Glipizide is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may occur if high blood sugar is not treated). Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
Related Packages: 68382-0184-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Glipizide
Metformin is used alone or with other medications, including insulin, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Metformin is in a class of drugs called biguanides. Metformin helps to control the amount of glucose (sugar) in your blood. It decreases the amount of glucose you absorb from your food and the amount of glucose made by your liver. Metformin also increases your body's response to insulin, a natural substance that controls the amount of glucose in the blood. Metformin is not used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
Related Packages: 68382-0184-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Metformin
Product Information
| NDC | 68382-0184 |
|---|---|
| Product ID | 68382-184_6a952de4-8cf7-4c86-87a3-8054c6993288 |
| Associated GPIs | 27997002350320 |
| GCN Sequence Number | 051194 |
| GCN Sequence Number Description | glipizide/metformin HCl TABLET 2.5-250 MG ORAL |
| HIC3 | C4S |
| HIC3 Description | ANTIHYPERGLYCEMIC,INSULIN-RELEASE STIM.-BIGUANIDE |
| GCN | 18366 |
| HICL Sequence Number | 024429 |
| HICL Sequence Number Description | GLIPIZIDE/METFORMIN HCL |
| Brand/Generic | Generic |
| Proprietary Name | Glipizide and Metformin Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Glipizide and Metformin Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 2.5; 250 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | GLIPIZIDE; METFORMIN HYDROCHLORIDE |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078905 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68382-0184-01 (68382018401)
| NDC Package Code | 68382-184-01 |
|---|---|
| Billing NDC | 68382018401 |
| Package | 100 TABLET, FILM COATED in 1 BOTTLE (68382-184-01) |
| Marketing Start Date | 2016-05-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.24808 |
| Pricing Unit | EA |
| Effective Date | 2023-09-20 |
| NDC Description | GLIPIZIDE-METFORMIN 2.5-250 MG |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |